QA: Ernexa Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2026_Ernexa_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Ernexa Therapeutics Inc

  xvar xval
0 AssetsCurrent 3,133,000
1 IntangibleAssetsNetIncludingGoodwill 2,044,000
2 PropertyPlantAndEquipmentNet 94,000
3 remainder_Assets 563,000
4 LiabilitiesCurrent 3,113,000
5 LiabilitiesNoncurrent 320,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 19,851
8 SellingGeneralAndAdministrativeExpense 5,783,447
9 ResearchAndDevelopmentExpense 4,184,003
10 remainder_Expenses -549,569
11 remainder_Revenues -105,083
12 remainder_NetIncome -14,557,297
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,834,000
1 Liabilities 3,433,000
2 Expenses 9,437,732
3 Revenues -105,083
4 StockholdersEquity 2,401,000
5 NetIncome -24,100,112
6 ComprehensiveNetIncome -24,100,112
7 BaseVar 16,683,556
8 EconomicCapitalRatiobeforeLimitedLiability -4.07
9 EconomicCapitalRatio 0.374

Edgar->Model Mapping

Feature Distribution

Change over Time